Naema Nayyar
11PUBLICATIONS
81CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (11)
Sort by Publication Date:
|Dec 22, 2023
The ERK inhibitor LY3214996 augments anti-PD-1 immunotherapy in preclinical mouse models of BRAFV600E melanoma brain metastasis.Magali A de Sauvage, Consuelo Torrini, Edwin Nieblas-Bedolla
|Aug 23, 2023
CDK4/6 Inhibition Sensitizes Intracranial Tumors to PD-1 Blockade in Preclinical Models of Brain Metastasis.Naema Nayyar, Magali A de Sauvage, Jane Chuprin
|Aug 01, 2023
Association of MTHFR Polymorphisms With Leukoencephalopathy Risk in Patients With Primary CNS Lymphoma Treated With Methotrexate-Based Regimens.Philipp Karschnia, Sylvia C Kurz, Priscilla K Brastianos
|Jun 16, 2022
Microenvironmental Landscape of Human Melanoma Brain Metastases in Response to Immune Checkpoint Inhibition.Christopher Alvarez-Breckenridge, Samuel C Markson, Jackson H Stocking
|Mar 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.Priscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder
|Nov 26, 2021
Author Correction: Genomic and transcriptomic correlates of immunotherapy response within the tumor microenvironment of leptomeningeal metastases.Sanjay M Prakadan, Christopher A Alvarez-Breckenridge, Samuel C Markson
Pageof 2
Frequent Collaborators
7 joint publications
Priscilla K Brastianos
5 joint publications
Michael White
5 joint publications
Scott L Carter
5 joint publications
Joana Mora
4 joint publications
Albert E Kim
4 joint publications
Ryan J Sullivan
3 joint publications
Corey M Gill
3 joint publications
Jackson H Stocking
3 joint publications
Robert H Klein
3 joint publications
Magali De Sauvage
